Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.
about
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A HypothesisPathophysiology of diabetic retinopathyTherapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathyAspirin for diabetic retinopathyPrevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibitionLeukocyte-mediated endothelial cell injury and death in the diabetic retinaLeukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathyPulsatility of parafoveal capillary leukocytes.Selective uptake of indocyanine green by reticulocytes in circulation.Morphology and topography of retinal pericytes in the living mouse retina using in vivo adaptive optics imaging and ex vivo characterization.Scanning laser ophthalmoscopy and fundus fluorescent leucocyte angiography.Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4.Localization of vascular adhesion protein-1 (VAP-1) in the human eye.Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakageEffect of ranirestat, a new aldose reductase inhibitor, on diabetic retinopathy in SDT rats.Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cellsDiabetic retinopathy: targeting vasoregressionChoosing preclinical study models of diabetic retinopathy: key problems for considerationHyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathyAntagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy.Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.RNA-Seq reveals a role for NFAT-signaling in human retinal microvascular endothelial cells treated with TNFα.Altered L-selectin expression in lymphocytes and increased adhesion to endothelium in patients with diabetic retinopathyRetinal pericytes inhibit activated T cell proliferationProtein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational researchRNA-seq identifies a role for the PPARβ/δ inverse agonist GSK0660 in the regulation of TNFα-induced cytokine signaling in retinal endothelial cellsRetinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.Suppression of diabetic retinopathy with angiopoietin-1.Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid.Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling.Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy.Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acidBloodstream-To-Eye Infections Are Facilitated by Outer Blood-Retinal Barrier DysfunctionProgression of Diabetic Capillary Occlusion: A Model.Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b study.Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy.Blood-Retinal Barrier Compromise and Endogenous Staphylococcus aureus EndophthalmitisPresence of retinal pericyte-reactive autoantibodies in diabetic retinopathy patients.
P2860
Q26768638-0652B722-DB2F-42B6-AF51-559A5E27A4D7Q26865897-7F3F6310-9C94-4EAF-B134-01957D3C33D7Q27021701-88DC584F-2921-462F-B7BF-DE95DD5B3C94Q28165996-654DC428-140D-4340-851F-6B3FE453A122Q28343572-680C7368-0DF6-46D3-BA67-725473023D1EQ28345653-59F27C6E-F964-45B7-B5C4-E88C49CE681CQ28576755-C1C10F9E-3A02-4DE3-A06B-16ED8D9AE012Q30488203-EC1973B3-A685-4A54-A9E5-E103292B5B18Q30493423-4F9D9527-2785-4494-ABB9-9A9B3722652EQ30560244-FD76F13C-0DE0-4E96-8CAB-BED847D2D752Q30801133-1C2D2389-6BD9-47AB-8177-2F840BA30533Q33556542-90941D00-DA60-42DA-9F6D-023779F1BCE5Q33677290-C283FDB9-5A2C-45DB-A43A-5C585EF0E1C4Q34082890-12DA8AE7-C7A3-43B8-8ACF-06D5208BA8BCQ34152215-F6B84B08-43FE-4AF8-A129-86F271767705Q34390960-EF6CAAC3-27CE-4673-A875-4B0243874E25Q34448837-4DA524E3-852B-4B27-8B9B-2BBD0AE2ED02Q34564352-814150B3-5AD6-4E5B-9823-949B8B8B3840Q34950714-058DE36F-A7F6-4EA3-837A-FFBCFFB37FCFQ35036412-DA7F90D6-0FC5-42CE-A86F-5FEE933690F4Q35346991-D0675D5A-E1A9-49E3-B62E-4AEACA66DF3AQ35548463-A3CF6099-9387-466D-A2E1-6BE08D5434C4Q35592432-B99FE1A5-DB2A-4362-864F-3DA3EF61A1BAQ35595555-90DD1EA9-A552-420F-9E82-67838EC584A4Q35615435-A2F4E02E-D4BC-4C4E-9A5E-053972497D51Q35645868-56E59FD9-2E97-4733-B127-9DE89004C618Q35747338-2DBFCB67-B0F6-4751-B023-641C15F9E1FDQ35748042-5F65E29E-94B1-4321-9E56-77732A3854DDQ35763445-6E11E72D-D767-48E6-8E11-0D2C0DCD5332Q35797625-BAA5C1A2-F9F3-4F6D-99D3-86B9C904BE82Q35798412-643DB0BD-6DF2-4B64-9B06-A2C9EC538C92Q35810089-48DB87F8-6D58-4A70-BD26-59412A5F185FQ35892696-C6FB47F3-77F6-438F-B658-FB2A29C33CCDQ35989359-9E53922F-D55B-4DFE-87FB-D736AFBFA60CQ36022227-3185B169-8BD9-43F1-B228-8EAA2F90FF64Q36051940-4CCD9076-2FCB-4443-95AB-C30F5D398E1EQ36093262-4561C781-2630-4BF7-B9DC-E58338ADBC1DQ36145936-62C7ADAB-45D0-48DB-8A03-DC723F07422FQ36273810-639FD050-D7C7-4198-8BC7-AC55ABF4A6D3Q36536081-C0640428-11AC-4AD2-8999-F10156687EA5
P2860
Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Activated monocytes and granul ...... ation in diabetic retinopathy.
@en
Activated monocytes and granul ...... ation in diabetic retinopathy.
@nl
type
label
Activated monocytes and granul ...... ation in diabetic retinopathy.
@en
Activated monocytes and granul ...... ation in diabetic retinopathy.
@nl
prefLabel
Activated monocytes and granul ...... ation in diabetic retinopathy.
@en
Activated monocytes and granul ...... ation in diabetic retinopathy.
@nl
P2093
P2860
P1476
Activated monocytes and granul ...... ation in diabetic retinopathy.
@en
P2093
Palinski W
Schmid-Schönbein GW
Schröder S
P2860
P304
P407
P577
1991-07-01T00:00:00Z